drugset / Trial / NCT04747301

DOuble-BAlloon Versus PROstaglandin E2 for Cervical Ripening in Low Risk Pregnancies

NCT04747301

RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the effectiveness and safety of double balloon catheter and vaginal insert Prostaglandin E2 in cervical ripening prior to Induction of Labor in low-risk women from 39+0 to 40+6 weeks of gestation.

Timeline

Start
2021-08-01
Primary completion
2025-08-01
Completion
2025-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinoprostone Other / unclassified 10 mg

Indications

No indication recorded.